Luo Xiao

ORCID: 0000-0003-0112-9802
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Venous Thromboembolism Diagnosis and Management
  • Food Quality and Safety Studies
  • Pancreatitis Pathology and Treatment
  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Plant-based Medicinal Research
  • Blood Pressure and Hypertension Studies

Nanchang University
2025

Jiujiang First People's Hospital
2025

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic disease, also considered a metabolic syndrome, and associated with poor prognosis. eGDR (estimated glucose disposal rate) new biomarker to assessment insulin resistance (IR). The association between MASLD fibrosis currently unclear. aim of this cross-sectional study appraise fibrosis. This have enrolled 3,100 participants from 2017–2018 National Health Nutrition Examination Surveys (NHANES). Binary...

10.1186/s12902-025-01891-7 article EN cc-by-nc-nd BMC Endocrine Disorders 2025-03-11

To explore the effect of Naoxintong (NXT) on warfarin anticoagulation therapy and its potential mechanism. TCSMP, SwissTargetprediction, SuperPred, SEA, Batmanic-TCM were used to search for active ingredients targets NXT warfarin; DisGENT database was find disease coagulation disorders. Cytoscape software applied construct "drug-target"network; protein interaction network (PPI) study protein-protein interaction. GO KEGG functional analysis. The then tested in rats by analyzing factors blood...

10.2147/pgpm.s489820 article EN cc-by-nc Pharmacogenomics and Personalized Medicine 2025-01-01
Coming Soon ...